Simon Hirschmann

735 total citations
26 papers, 563 citations indexed

About

Simon Hirschmann is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Simon Hirschmann has authored 26 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 13 papers in Epidemiology and 13 papers in Immunology. Recurrent topics in Simon Hirschmann's work include Inflammatory Bowel Disease (15 papers), Microscopic Colitis (12 papers) and Immune Cell Function and Interaction (4 papers). Simon Hirschmann is often cited by papers focused on Inflammatory Bowel Disease (15 papers), Microscopic Colitis (12 papers) and Immune Cell Function and Interaction (4 papers). Simon Hirschmann collaborates with scholars based in Germany, Austria and United Kingdom. Simon Hirschmann's co-authors include Markus F. Neurath, Raja Atreya, Timo Räth, Clemens Neufert, Imke Atreya, Sebastian Zundler, H Schmitt, Anika Fischer, Maximilian J. Waldner and Sophia Sonnewald and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

Simon Hirschmann

24 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Hirschmann Germany 13 350 274 191 92 55 26 563
M E Fisfalen United States 10 472 1.3× 424 1.5× 51 0.3× 80 0.9× 72 1.3× 14 763
Simone Pasini Italy 8 108 0.3× 103 0.4× 102 0.5× 74 0.8× 75 1.4× 12 394
R Nissinen Finland 8 165 0.5× 122 0.4× 58 0.3× 116 1.3× 36 0.7× 25 359
A. Parikh United States 6 217 0.6× 120 0.4× 180 0.9× 71 0.8× 53 1.0× 14 335
Marta Rusmini Italy 12 69 0.2× 130 0.5× 83 0.4× 85 0.9× 218 4.0× 22 467
Jessica R. de Bruyn Netherlands 9 374 1.1× 77 0.3× 239 1.3× 188 2.0× 33 0.6× 10 455
Jörg Bertrams Germany 11 219 0.6× 203 0.7× 51 0.3× 157 1.7× 61 1.1× 16 470
Hiroki Sonoyama Japan 13 147 0.4× 61 0.2× 151 0.8× 174 1.9× 59 1.1× 35 388
Mouna Stayoussef Tunisia 13 128 0.4× 146 0.5× 67 0.4× 80 0.9× 64 1.2× 34 395
Tommaso Stefanelli Italy 7 81 0.2× 161 0.6× 47 0.2× 59 0.6× 63 1.1× 24 490

Countries citing papers authored by Simon Hirschmann

Since Specialization
Citations

This map shows the geographic impact of Simon Hirschmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Hirschmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Hirschmann more than expected).

Fields of papers citing papers by Simon Hirschmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Hirschmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Hirschmann. The network helps show where Simon Hirschmann may publish in the future.

Co-authorship network of co-authors of Simon Hirschmann

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Hirschmann. A scholar is included among the top collaborators of Simon Hirschmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Hirschmann. Simon Hirschmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirschmann, Simon, et al.. (2021). Case report of severe constrictive perimyocarditis and ischemic hepatitis in a Crohn’s disease patient upon infliximab-induced lupus-like syndrome. Therapeutic Advances in Gastroenterology. 14. 1088227009–1088227009. 1 indexed citations
2.
Fischer, Sarah, H Schmitt, Francesco Vitali, et al.. (2021). Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab. Therapeutic Advances in Gastroenterology. 14. 3974171666–3974171666. 19 indexed citations
3.
Becker, Emily, Lisa Müller, Simon Hirschmann, et al.. (2020). Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study. BMC Gastroenterology. 20(1). 103–103. 20 indexed citations
4.
Ganzleben, Ingo, Simon Hirschmann, Florian Fuchs, et al.. (2020). Successful Therapy of Crohn's Disease–Associated Pulmonary Necrobiotic Nodules on Ustekinumab Therapy. The American Journal of Gastroenterology. 115(4). 632–634.
5.
Ganzleben, Ingo, Carol I. Geppert, Lourdes Osaba, et al.. (2020). Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis. Therapeutic Advances in Gastroenterology. 13. 3974142976–3974142976. 14 indexed citations
6.
Fischer, Sarah, H Schmitt, Francesco Vitali, et al.. (2020). P548 Efficacy, safety, and pharmacokinetics after switching from infliximab originator to biosimilar SB2 in inflammatory bowel disease patients: A long-term observational, prospective cohort study. Journal of Crohn s and Colitis. 14(Supplement_1). S466–S467. 1 indexed citations
7.
Hirschmann, Simon, Barbara Schuster, Raja Atreya, et al.. (2019). P763 Addiction in IBD patients: more than just smoke?. Journal of Crohn s and Colitis. 13(Supplement_1). S502–S503. 1 indexed citations
8.
Atreya, Raja, Arndt Hartmann, Sarah Fischer, et al.. (2019). Magnification endoscopy with optical chromoendoscopy shows strong correlation with histologic inflammation in patients with inflammatory bowel disease. SHILAP Revista de lepidopterología. 7(8). E1018–E1026. 8 indexed citations
9.
Schmitt, H, Ulrike Billmeier, Walburga Dieterich, et al.. (2018). Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn’s disease. Gut. 68(5). 814–828. 184 indexed citations
10.
Simón, David, Arnd Kleyer, Matthias Englbrecht, et al.. (2018). A comparative analysis of articular bone in large cohort of patients with chronic inflammatory diseases of the joints, the gut and the skin. Bone. 116. 87–93. 26 indexed citations
11.
Atreya, Raja, Simon Hirschmann, Sarah Fischer, et al.. (2017). Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles. Frontiers in Immunology. 8. 764–764. 41 indexed citations
12.
Voskens, Caroline, Anika Fischer, Carmen Lorenz, et al.. (2017). Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis. Inflammatory Bowel Diseases. 23(8). 1348–1359. 26 indexed citations
13.
Hirschmann, Simon, Raja Atreya, Matthias Englbrecht, & Markus F. Neurath. (2017). Safety and efficacy of intravenous cyclophosphamide pulse therapy in therapy refractory Crohn's disease patients.. PubMed. 68(1). 57–67. 1 indexed citations
14.
Hirschmann, Simon & Markus F. Neurath. (2017). Top-down approach to biological therapy of Crohn’s disease. Expert Opinion on Biological Therapy. 17(3). 285–293. 14 indexed citations
15.
Haschka, Judith, Simon Hirschmann, Arnd Kleyer, et al.. (2016). High-resolution Quantitative Computed Tomography Demonstrates Structural Defects in Cortical and Trabecular Bone in IBD Patients. Journal of Crohn s and Colitis. 10(5). 532–540. 29 indexed citations
16.
Fischer, Anika, Sebastian Zundler, Raja Atreya, et al.. (2015). Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo. Gut. 65(10). 1642–1664. 120 indexed citations
17.
Heß, Andreas, Marc Saake, Marina G. Sergeeva, et al.. (2015). Functional Brain Imaging Reveals Rapid Blockade of Abdominal Pain Response Upon Anti-TNF Therapy in Crohn’s Disease. Gastroenterology. 149(4). 864–866. 21 indexed citations
18.
Hahn, Markus, Alexander Hagel, Simon Hirschmann, et al.. (2014). Modern diagnosis of celiac disease and relevant differential diagnoses in the case of cereal intolerance. Allergo Journal International. 23(2). 67–77. 12 indexed citations
19.
Steiner, Stefanie, Carolin Daniel, Anika Fischer, et al.. (2014). Cyclosporine A Regulates Pro-Inflammatory Cytokine Production in Ulcerative Colitis. Archivum Immunologiae et Therapiae Experimentalis. 63(1). 53–63. 12 indexed citations
20.
Hahn, Markus, Alexander Hagel, Simon Hirschmann, et al.. (2014). Moderne Diagnostik der Zöliakie und relevante Differenzialdiagnosen bei Getreideunverträglichkeiten. Allergo Journal. 23(2). 31–43. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M E Fisfalen Breakdown of academic impact, for papers by Simone Pasini Breakdown of academic impact, for papers by R Nissinen Breakdown of academic impact, for papers by A. Parikh Breakdown of academic impact, for papers by Marta Rusmini Breakdown of academic impact, for papers by Jessica R. de Bruyn Breakdown of academic impact, for papers by Jörg Bertrams Breakdown of academic impact, for papers by Hiroki Sonoyama Breakdown of academic impact, for papers by Mouna Stayoussef Breakdown of academic impact, for papers by Tommaso Stefanelli
Rankless by CCL
2026